CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 101 filers reported holding CARA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,433,000 | -19.2% | 692,518 | -27.4% | 0.00% | -50.0% |
| Q3 2016 | $7,966,000 | +83.3% | 954,036 | +5.6% | 0.00% | +100.0% |
| Q2 2016 | $4,347,000 | -19.7% | 903,747 | +3.8% | 0.00% | 0.0% |
| Q1 2016 | $5,413,000 | -62.4% | 870,309 | +2.0% | 0.00% | -66.7% |
| Q4 2015 | $14,384,000 | +11.5% | 853,145 | -5.5% | 0.00% | 0.0% |
| Q3 2015 | $12,903,000 | +43.9% | 902,949 | +22.4% | 0.00% | +50.0% |
| Q2 2015 | $8,965,000 | +100.1% | 737,882 | +65.5% | 0.00% | +100.0% |
| Q1 2015 | $4,481,000 | +7.7% | 445,858 | +6.8% | 0.00% | 0.0% |
| Q4 2014 | $4,161,000 | +280.7% | 417,388 | +220.3% | 0.00% | – |
| Q3 2014 | $1,093,000 | -52.7% | 130,322 | -4.0% | 0.00% | -100.0% |
| Q2 2014 | $2,310,000 | -16.3% | 135,696 | -8.5% | 0.00% | 0.0% |
| Q1 2014 | $2,760,000 | – | 148,322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |